3HP5
Crystal Structure of Human p38alpha complexed with a pyrimidopyridazinone compound
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 17-BM |
Synchrotron site | APS |
Beamline | 17-BM |
Temperature [K] | 110 |
Detector technology | CCD |
Collection date | 2001-08-15 |
Detector | MAR CCD 165 mm |
Wavelength(s) | 1.0 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 65.045, 74.022, 76.697 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 37.010 - 2.300 |
R-factor | 0.21666 |
Rwork | 0.214 |
R-free | 0.26185 |
Structure solution method | FOURIER SYNTHESIS |
RMSD bond length | 0.009 |
RMSD bond angle | 1.279 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 40.000 | 2.380 |
High resolution limit [Å] | 2.300 | 2.300 |
Rmerge | 0.062 | 0.449 |
Number of reflections | 15856 | |
<I/σ(I)> | 21.35 | 2.1 |
Completeness [%] | 92.7 | 63.6 |
Redundancy | 3.7 | 3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 9 | 298 | 20-30% PEG3000, 10 mM CaCl2, 50 mM CHES, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K |